With support from recent legislation as well as advocacy from researchers, academic medicine is making greater inroads into medical practices. But the practice known as academic detailing has prompted criticism from pharmaceutical manufacturers and others who claim that lax oversight is opening the door to unintended consequences such as lowering the quality of care in return for cost savings.
Academic detailing is noncommercial education of health care professionals, typically conducted by physicians, pharmacists, and nurses, about the evidence-based efficacy, safety, and cost of therapies. It is designed to counter detailing by pharmaceutical and device manufacturers, which critics contend can be biased because of commercial interests.
Mitka M. New Physician Education Initiatives Seek to Remove the Devil From the Detailing. JAMA. 2011;306(11):1187-1188. doi:10.1001/jama.2011.1256